Clinical trial
Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte…
NCT00004474 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00004474 |
|---|---|
| Title | Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia |
| Official title | Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Aplastic Anemia |
| Intervention type | Drug, Procedure |
| Interventions | Anti-thymocyte globulin, Cyclophosphamide, Bone marrow transplantation |
| Enrollment | 224 |
| Start date | Sep 1, 1998 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 12, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: